Watch OPK. Know when insiders buy.
One email the day a filing lands. Free.
OPK
OPKO HEALTH, INC.
1.64
−0.06 −3.53%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
43
WATCH · shorts 43
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.4BP/E —DIV YIELD —FCF YIELD -5.47%REV TTM $587.9M −11.5%NET INCOME −$72.9MNET DEBT $48.3M52W 1.10 – 1.70SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $163.6M | +4.3% | 48.9% | −$7M | −$8.4M | — | -0.01 | −$43.5M | $3M | −$46.5M | Aug 28 |
| Q1 2026 · Mar 31 | $124.2M | −17.2% | 36.8% | −$51M | −$54.8M | — | -0.07 | −$19.3M | $1.8M | −$21.1M | Aug 28 |
| Q4 2025 · Dec 31 | $148.5M | −19.2% | 43.1% | −$38.3M | −$31.3M | −322.8% | -0.04 | −$25.9M | $2.7M | −$28.6M | Feb 26 |
| Q3 2025 · Sep 30 | $151.7M | −12.6% | 32.9% | $48.1M | $21.6M | −13.1% | 0.03 | −$34.6M | $3.1M | −$37.8M | Feb 26 |
| Q2 2025 · Jun 30 | $156.8M | −13.9% | 31.5% | −$60M | −$148.4M | — | -0.19 | −$83.4M | $3.3M | −$86.7M | Aug 28 |
| Q1 2025 · Mar 31 | $150M | −13.7% | 28.4% | −$67.2M | −$67.6M | — | -0.10 | −$34.6M | $3.2M | −$37.7M | Aug 28 |
| Q4 2024 · Dec 31 | $183.6M | +1.0% | 46.1% | −$33.1M | $14M | — | 0.01 | −$44.4M | $5.4M | −$49.8M | Feb 26 |
| Q3 2024 · Sep 30 | $173.6M | −2.8% | 23.1% | −$67.2M | $24.9M | — | 0.03 | −$77.1M | $7.9M | −$85M | Aug 28 |
| Q2 2024 · Jun 30 | $182.2M | — | 28.4% | −$61.7M | −$10.3M | — | -0.01 | −$26.4M | $7.2M | −$33.7M | Feb 26 |
| Q1 2024 · Mar 31 | $173.7M | — | 24.2% | −$71.5M | −$81.8M | — | -0.12 | −$35.6M | $4.4M | −$40M | Feb 26 |
| Q4 2023 · Dec 31 | $181.9M | — | — | −$69M | −$66.5M | — | -0.09 | −$38.3M | $3M | −$41.3M | Feb 26 |
| Q3 2023 · Sep 30 | $178.6M | — | — | −$64.4M | −$84.5M | — | -0.11 | $33.1M | $4.2M | $28.9M | Mar 3 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $606.9M | 33.9% | −$117.4M | −$225.7M | -37.2% | -0.30 | −$178.5M | $12.3M | −$190.8M | $47M | — |
| FY2024 · to Dec 31 | $713.1M | 30.6% | −$152.1M | −$53.2M | -7.5% | -0.08 | −$183.5M | $25M | −$208.5M | $90.2M | — |
| FY2023 · to Dec 31 | $863.5M | 36.8% | −$157M | −$188.9M | -21.9% | -0.25 | −$28.2M | $16.3M | −$44.5M | $0 | — |
| FY2022 · to Dec 31 | $1B | 28.7% | −$226.3M | −$328.4M | -32.7% | -0.46 | −$95.2M | $24.6M | −$119.8M | $0 | — |
| FY2021 · to Dec 31 | $1.8B | — | $18.8M | −$30.1M | -1.7% | -0.05 | $38.3M | $32.2M | $6.2M | — | — |
| FY2020 · to Dec 31 | $1.4B | — | $57.7M | $30.6M | 2.1% | 0.05 | $39.5M | $33.7M | $5.8M | — | — |
Every number comes from OPKO HEALTH, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.